 |
Press Releases
New Report Examines the Neurosurgery Drugs Market Research
, 12 January 2018 -- Neurosurgery Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025
Neurosurgery is a surgical specialty concerned with the treatment of disorders and diseases related to the spinal cord, sympathetic and peripheral nervous system, and brain. Medications related to neurosurgical conditions include four drugs: Phenytek, Phenytoin Sodium, Dilantin, and Phenytoin. These are anti-epileptic drug or anticonvulsant. Epilepsy causes recurrent seizures that are unprovoked by neurologic insults or acute systemic. Phenytoin is used to control these seizures by slowing down brain impulses caused by this disorder. Seizures can occur due to bleeding in the brain caused by injuries, brain tumors, or brain surgery. Phenytoin sodium is included under the drug class Hydantoins. Phenytoin is a hydantoin derivative anticonvulsant drug. Phenytoin sodium is used to reduce neuropathic pain, cardiac glycoside intoxication, cardiac arrhythmias, status epilepticus, seizures associated with neurosurgery, absence (petit mal) seizures, partial seizures, and tonic-clonic seizures.
Long-term side effects of cerebellar ataxia and osteopenia, reduce their use by neurologists. Neurosurgery drugs have narrow therapeutic index and zero-order kinetics that makes these drugs to be one of the most difficult antiepileptic drugs to use. Moreover, these drugs are likely to have significant bidirectional drug interactions. Some neurosurgery drugs may cause difficulty in coordinating movements, confusion, headaches, nausea, dizziness, and drowsiness. If these drugs are ingested during pregnancy, they can causing various abnormalities in the baby.
The neurosurgery drugs market is driven by the rise in geriatric population with neurological disorders. The Global Campaign against Epilepsy sponsored by the International League against Epilepsy, the International Bureau for Epilepsy, and the World Health Organization advocates using phenobarbital to increase health promotions in low-income countries. This projected to boost the neurosurgery drugs market. According to the book Neurological Disorders, written by Rajesh Pandav, Ramanan Laxminarayan, Vijay Chandra, and others, states that a study conducted in developed countries on people who underwent epilepsy surgery indicated that 58% of them are seizure free, while 10% to 15% people have less frequent seizures, and even if the patients have less or no seizures, medications need to be continued for one to two years.
This is projected to support the expansion of the neurosurgery drugs market. Statistics from the World Health Organization suggests that the global burden of neurological diseases was approximately 92 million disability-adjusted life years (DALYs) in 2005 and is estimated to reach 103 million DALYs by the end of 2030. Rapidly increasing burden of neurological diseases is likely to increase the number of neurological surgeries, thereby increasing the demand for neurosurgery drugs.
The neurosurgery drugs market can be segmented based on drug class, disease type, distribution channel, and region. In terms of drug class, the market can be categorized into hydantion anticonvulsants, and group I antiarrhythmics. Based on disease type, the neurosurgery drugs market can be classified into neuropathic pain, cardiac glycoside intoxication, cardiac arrhythmias, status epilepticus, seizures associated with neurosurgery, absence (petit mal) seizures, partial seizures, and tonic-clonic seizures. In terms of the distribution channel, the market can be segmented into retail pharmacies, hospital pharmacies, and online pharmacies.
Based on geography, the neurosurgery drugs market can be divided into Latin America, Asia Pacific, Europe, North America, and Middle East & Africa. North America accounted for a large share of the market in 2016 owing to the increasing geriatric population and rise in research & development activities. Europe held the second large share of the market in 2016, due to rising stress levels and increasing inclination toward drug addiction for pain relief, which are expected to boost the demand for neurosurgery drugs. The market in Asia Pacific is anticipated to expand at a moderate pace during the forecast period owing to technological advancements and increasing stress levels in developed and developing countries. The market in Middle East & Africa and Latin America is projected to expand during the forecast period due to increasing health promotions in these countries.
Download Report Brochure @ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=37808
Key players operating in the neurosurgery drugs market are Pfizer Inc., Sun Pharmaceutical Industries Limited, WOCKHARDT, and Mylan N.V.
# # #
Submitted by Sandy Researcher, Transparency Market Research on Friday, 12 January 2018 at 6:33 PM
Category: Health Care & Medical
|
Related News
Root Canal Obturator Market Scope and Opportunities Analysis 2017 - 2025
Tuesday, 24 Apr 2018
DNA Polymerase Market Latest Trends and Future Growth Study by 2025
Tuesday, 24 Apr 2018
Gas Chromatography Systems Market Share and Growth Factors Impact Analysis 2017 - 2025
Tuesday, 24 Apr 2018
Additive Manufacturing Technologies Market Competitive Landscape Analysis with Forecast by 2025
Tuesday, 24 Apr 2018
Foley Catheter Market Current Trends and Future Aspect Analysis 2017 - 2025
Tuesday, 24 Apr 2018
|
Related Events
RNASeq Summit
Tuesday, 24 Apr 2018
European Neoantigen Summit
Tuesday, 24 Apr 2018
Antigen- Specific Immune Tolerance Drug Development Summit
Tuesday, 24 Apr 2018
2018 eRegulatory Summit, Lisbon
Tuesday, 24 Apr 2018
Work 2.0
Tuesday, 24 Apr 2018
|
Latest News
The Fast Crime Scene Cleanup Services
Wednesday, 25 Apr 2018
Daily Comex Report of 25 April 2018 by Epic Research
Wednesday, 25 Apr 2018
Jeffree Star Plastic Surgery Before and After – Most Vital Tips
Wednesday, 25 Apr 2018
Hurry to Buy RS 3 Gold with 6% off&Double Points for T92 dyes Until May.2
Wednesday, 25 Apr 2018
Labor Day Promo:OSRS Gold with 6% off&Double Points for Bryophyta Until May.2
Wednesday, 25 Apr 2018
|
|
 |
Scoopasia v1.0b. Copyright © 2018
Today is Wednesday, 25 April 2018
About Scoopasia |
FAQ |
Privacy Policy |
Contact Us
|
|
|